WallStSmart
PGEN

Precigen Inc

NASDAQ: PGEN · HEALTHCARE · BIOTECHNOLOGY

$4.16
+0.97% today

Updated 2026-04-30

Market cap
$1.46B
P/E ratio
P/S ratio
150.58x
EPS (TTM)
$-1.37
Dividend yield
52W range
$1 – $5
Volume
4.6M

Precigen Inc (PGEN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-79.5%
Last 4 quarters
Revenue YoY growth
+283.6%
Most recent quarter
EPS YoY growth
-100.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+9.7%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+20.6%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-09$-0.07+20.3%$3.32$3.51+5.7%
2025-11-13$-1.06-1077.8%$4.02$4.85+20.6%
2025-08-13$-0.09-8.0%$1.80$1.85+2.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.08$-0.07+20.3%$4.57M+283.6%
2025-09-30$-0.09$-1.06-1077.8%$2.92M+206.6%
2025-06-30$-0.08$-0.09-8.0%$856000.00+19.4%
2025-03-31$-0.08$-0.18-130.4%$1.34M+25.9%
2024-12-31$-0.05$-0.03+37.0%$1.19M-3.1%
2024-09-30$-0.08$-0.09-9.1%$953000.00-30.9%
2024-06-30$-0.10$-0.10+0.0%$717000.00-59.4%
2024-03-31$-0.09$-0.10-11.1%$1.06M
2023-12-31$-0.08$-0.13-62.5%$1.23M
2023-09-30$-0.08$-0.08+0.0%$1.38M
2023-06-30$-0.10$-0.08+20.0%$1.77M

Frequently asked questions

Has Precigen Inc beaten earnings estimates?
Precigen Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -79.5% over the last 4 quarters.
How does PGEN stock react to earnings?
PGEN stock has moved an average of +9.7% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Precigen Inc's revenue growth rate?
Precigen Inc reported year-over-year revenue growth of +283.6% in its most recent quarter, with EPS growing -100.6% year-over-year.